1 | TM-1 | 09 May 2001 |
10 | Affidavit | 11 Oct 2010 |
11 | TM-12 | 09 May 2011 |
12 | Correspondence | 01 Oct 2011 |
13 | TM-50 | 14 Feb 2017 |
14 | TM-R(RENEWAL OF TRADE MARK) | 08 Feb 2021 |
15 | TM-P(ALTER ADDRESS OF REGISTERED PROP/USER) | 08 Feb 2021 |
2 | Certificate | 14 May 2001 |
2 | Examination Report | 14 May 2001 |
3 | Additional Representation Sheet | 14 May 2001 |
3 | Note Sheet | 14 May 2001 |
4 | TM-1 | 14 May 2001 |
5 | Certificate | 14 May 2001 |
5 | Note Sheet | 14 May 2001 |
6 | Additional Representation Sheet | 14 May 2001 |
6 | Examination Report | 14 May 2001 |
7 | Journal Copy | 10 Jun 2009 |
8 | Additional Representation Sheet | 10 Jun 2009 |
9 | Note Sheet | 10 Jun 2009 |
1 | RENEWAL INTIMATION LETTER | 11096086 | 12 Feb 2021 |
The application for Mbkacin was made on 14 May 2001.
The trademark applicant for Mbkacin is ABBOTT HEALTHCARE.
Mbkacin is applied in class(es) 5.
Application for Mbkacin is on Registered stage.
Application Id allotted to Mbkacin is 1009022.
Trademark agent or attorney for the application is Zeusip.
Mbkacin filed with the Intellectual property office as a WORD.